Skip Navigation


European Heart Journal Advance Access originally published online on February 4, 2005
European Heart Journal 2005 26(5):426-427; doi:10.1093/eurheartj/ehi141
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/5/426    most recent
ehi141v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Coats, A. J.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coats, A. J.S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Why ventilatory inefficiency matters in chronic heart failure

Andrew J.S. Coats*

University of Sydney, NSW 2006, Australia

* Corresponding author. Tel: +61 235 14579; fax: +61 235 16645. E-mail address: ajscoats@aol.com

This editorial refers to ‘Exercise ventilation inefficiency and cardiovascular mortality in heart failure: the critical independent prognostic value of the arterial CO2 partial pressure’{dagger} by M. Guazzi et al., on page 472

The first 10% of the full text of this article appears below.

Chronic heart failure is a common condition with a poor prognosis. Major treatment advances have been achieved utilizing three main drug classes: the angiotensin-converting enzyme inhibitors (and the similarly acting angiotensin receptor antagonists), beta-blockers, and aldosterone antagonists. Despite our increased knowledge of the pathophysiology of the condition, the generation of symptoms and the causes of exercise intolerance remain confusing. Establishing accurate risk stratification has also proved difficult. While a logical measure such as left ventricular ejection fraction,1 reflecting as it does damage . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Exercise ventilation inefficiency and cardiovascular mortality in heart failure: the critical independent prognostic value of the arterial CO2 partial pressure
Marco Guazzi, Giuseppe Reina, Gabriele Tumminello, and Maurizio D. Guazzi
EHJ 2005 26: 472-480. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Eur Heart JHome page
G. Tumminello, M. Guazzi, P. Lancellotti, and L. A. Pierard
Exercise ventilation inefficiency in heart failure: pathophysiological and clinical significance
Eur. Heart J., March 2, 2007; 28(6): 673 - 678.
[Abstract] [Full Text] [PDF]